Clinical Trials
4
Active:0
Completed:2
Trial Phases
2 Phases
Phase 2:2
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (50.0%)Phase 3
2 (50.0%)SM-1 vs. an Active Comparator in A Model of Transient Insomnia
- First Posted Date
- 2020-05-20
- Last Posted Date
- 2020-05-20
- Lead Sponsor
- Sequential Medicine Ltd
- Target Recruit Count
- 14
- Registration Number
- NCT04396327
- Locations
- 🇺🇸
Clinilabs Drug Development Corporation, New York, New York, United States
An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia
- First Posted Date
- 2017-11-09
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Sequential Medicine Ltd
- Registration Number
- NCT03338764
SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.
- First Posted Date
- 2017-11-06
- Last Posted Date
- 2019-06-05
- Lead Sponsor
- Sequential Medicine Ltd
- Target Recruit Count
- 85
- Registration Number
- NCT03331042
- Locations
- 🇺🇸
NeuroTrials Research, Inc., Atlanta, Georgia, United States
🇺🇸Clinilabs, Inc., New York, New York, United States
Pilot Study of a Combination Drug Product for Treatment of Short-term Insomnia
- First Posted Date
- 2016-02-02
- Last Posted Date
- 2018-03-06
- Lead Sponsor
- Sequential Medicine Ltd
- Target Recruit Count
- 39
- Registration Number
- NCT02671760
News
No news found